Compare ADVB & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADVB | AMTX |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | United States |
| Employees | 31 | N/A |
| Industry | Medical Specialities | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.2M | 98.6M |
| IPO Year | N/A | 2023 |
| Metric | ADVB | AMTX |
|---|---|---|
| Price | $3.72 | $1.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 90.0K | ★ 974.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $77,194,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $139.04 |
| P/E Ratio | $1.26 | ★ N/A |
| Revenue Growth | N/A | ★ 174.60 |
| 52 Week Low | $0.19 | $1.22 |
| 52 Week High | $4.64 | $3.66 |
| Indicator | ADVB | AMTX |
|---|---|---|
| Relative Strength Index (RSI) | 96.59 | 41.18 |
| Support Level | $0.38 | $1.27 |
| Resistance Level | N/A | $1.65 |
| Average True Range (ATR) | 0.14 | 0.09 |
| MACD | 0.47 | -0.02 |
| Stochastic Oscillator | 93.49 | 1.16 |
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.